Search Results - "Goorha, Salil"

Genomic analysis reveals few genetic alterations in pediatric acute myeloid leukemia by Radtke, Ina, Mullighan, Charles G, Ishii, Masami, Su, Xiaoping, Cheng, Jinjun, Ma, Jing, Ganti, Ramapriya, Cai, Zhongling, Goorha, Salil, Pounds, Stanley B, Cao, Xueyuan, Obert, Caroline, Armstrong, Jianling, Zhang, Jinghui, Song, Guangchun, Ribeiro, Raul C, Rubnitz, Jeffrey E, Raimondi, Susana C, Shurtleff, Sheila A, Downing, James R

“…Pediatric de novo acute myeloid leukemia (AML) is an aggressive malignancy with current therapy resulting in cure rates of only 60%. To better understand the…”
Get full text

Management of hyperglycemia in diabetic patients with hematologic malignancies during dexamethasone therapy by Gosmanov, Aidar R, Goorha, Salil, Stelts, Sundae, Peng, Limin, Umpierrez, Guillermo E

“…To compare the response to different insulin regimens for management of hyperglycemia in diabetic patients with hematologic malignancies who are receiving…”
Get more information

High-resolution genomic profiling of adult and pediatric core-binding factor acute myeloid leukemia reveals new recurrent genomic alterations by Kühn, Michael W.M., Radtke, Ina, Bullinger, Lars, Goorha, Salil, Cheng, Jinjun, Edelmann, Jennifer, Gohlke, Juliane, Su, Xiaoping, Paschka, Peter, Pounds, Stanley, Krauter, Jürgen, Ganser, Arnold, Quessar, Asmaa, Ribeiro, Raul, Gaidzik, Verena I., Shurtleff, Sheila, Krönke, Jan, Holzmann, Karlheinz, Ma, Jing, Schlenk, Richard F., Rubnitz, Jeffrey E., Döhner, Konstanze, Döhner, Hartmut, Downing, James R.

“…To identify cooperating lesions in core-binding factor acute myeloid leukemia, we performed single-nucleotide polymorphism-array analysis on 300 diagnostic and…”
Get full text

Using a standard implementation science framework to improve clinical trial enrollment for a community Tennessee oncology center by Jain, Neha M, Lammers, Philip Edward, Savona, Michael R., Osterman, Travis John, Goorha, Salil

“…e18586 Background: Recommendations for clinical trial consideration are ubiquitous across all cancers. However, it is challenging to identify patients from…”
Get full text

Allogeneic CD34+ selected hematopoietic stem cell boost following CAR T‐cell therapy in a patient with prolonged cytopenia and active infection by Lipsitt, Amanda, Beattie, Lisa, Harstead, Elaine, Li, Ying, Goorha, Salil, Maron, Gabriela, Gottschalk, Stephen, Triplett, Brandon, Naik, Swati

“…Hematological toxicity (hematotoxicity) leading to peripheral cytopenias is a common long‐term adverse effect following the use of CD19‐chimeric antigen…”
Get full text

Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia by Shurtleff, Sheila A, Pui, Ching-Hon, Radtke, Ina, Mullighan, Charles G, Dalton, James D, Pounds, Stanley B, Evans, William E, Goorha, Salil, Girtman, Kevin, Su, Xiaoping, Relling, Mary V, Coustan-Smith, Elaine, Ma, Jing, Downing, James R, Mathew, Susan, Miller, Christopher B

“…Chromosomal aberrations are a hallmark of acute lymphoblastic leukaemia (ALL) but alone fail to induce leukaemia. To identify cooperating oncogenic lesions, we…”
Get full text

Engaging Underrepresented Patients in Hematology Clinical Trials through the LLS Impact (Influential Medicine Providing Access to Clinical Trials) Research Grant: A Multi-Institutional Effort by Biltibo, Eden Ayele, Copeland, Zachary, Nelson, Erik, Logan, Nina, Jack, Kellie, Johnston, Jamie, Leautaud, Veronica, Philip, Lammers, Goorha, Salil, Randolph, Brion, Cohen, Jonathon B., Kives, Melissa, Yaffe, Michael, Greenberger, Lee M., Flowers, Christopher R., Siddiqi, Tanya, Smith, Clayton, Phillips, Erica, Leonard, John P., Nowakowski, Grzegorz S., Savona, Michael R.

“…Introduction: Despite governmental and industry-sponsored efforts, clinical trial participation among rural residents and racial and ethnic minorities remains…”
Get full text

Risk factors for mortality and progression to severe COVID-19 disease in the Southeast region in the United States: A report from the SEUS Study Group by Hobbs, Athena L V, Turner, Nicholas, Omer, Imad, Walker, Morgan K, Beaulieu, Ronald M, Sheikh, Muhammad, Spires, S Shaefer, Fiske, Christina T, Dare, Ryan, Goorha, Salil, Thapa, Priyenka, Gnann, John, Wright, Jeffrey, Nelson, George E

“…Identify risk factors that could increase progression to severe disease and mortality in hospitalized SARS-CoV-2 patients in the Southeast region of the United…”
Get full text

Intravascular B-cell lymphoma: an elusive diagnosis by Raza, Muhammad, Qayyum, Sohail, Raza, Shahnila, Goorha, Salil

Get full text

Evaluating the Impact of the Addition of Cladribine to Standard Acute Myeloid Leukemia Induction Therapy by Seligson, Nathan D., Hobbs, Athena L. V., Leonard, Joanna M., Mills, Elizabeth L., Evans, Amy G., Goorha, Salil

“…Background: Treatment for acute myeloid leukemia (AML) has remained relatively unchanged over the past few decades. Although recent drug approvals have…”
Get full text

In the Era of Bortezomib-Based Chemotherapy the Presence of Minimal Residual Disease Predicts Progression Free Survival after Autologous Hematopoietic Cell Transplant by Cornell, Robert F, Jones, Jade E, Mosse, Claudio A., Chen, Heidi, Dugger, Laura, Goorha, Salil, Chinratanalab, Wichai, Engelhardt, Brian, Goodman, Stacey A., Greer, John P, Lacy, Shelton, Kassim, Adetola A., McDonagh, Kevin, Savani, Bipin N., Sengsayadeth, Salyka, Jagasia, Madan

“…Background: Retrospective studies have shown that achieving minimal residual disease (MRD) by multi-parameter flow cytometry (MFC) is predictive of outcomes in…”
Get full text

Acute lymphoblastic leukemia by Alvarnas, Joseph C, Brown, Patrick A, Aoun, Patricia, Ballen, Karen Kuhn, Bellam, Naresh, Blum, William, Boyer, Michael W, Carraway, Hetty E, Coccia, Peter F, Coutre, Steven E, Cultrera, Jennifer, Damon, Lloyd E, DeAngelo, Daniel J, Douer, Dan, Frangoul, Haydar, Frankfurt, Olga, Goorha, Salil, Millenson, Michael M, O'Brien, Susan, Petersdorf, Stephen H, Rao, Arati V, Terezakis, Stephanie, Uy, Geoffrey, Wetzler, Meir, Zelenetz, Andrew D, Naganuma, Maoko, Gregory, Kristina M

“…The inaugural NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for acute lymphoblastic leukemia (ALL) were developed as a result of meetings…”
Get more information

Acute myeloid leukemia by O'Donnell, Margaret R, Abboud, Camille N, Altman, Jessica, Appelbaum, Frederick R, Coutre, Steven E, Damon, Lloyd E, Foran, James M, Goorha, Salil, Maness, Lori J, Marcucci, Guido, Maslak, Peter, Millenson, Michael M, Moore, Joseph O, Ravandi, Farhad, Shami, Paul J, Smith, B Douglas, Stone, Richard M, Strickland, Stephen A, Tallman, Martin S, Wang, Eunice S

Get more information

Fulminant soft-tissue extension of anaplastic multiple myeloma masquerading as postoperative abscess by Murphy, Robert F, Goorha, Salil, Heck, Robert K

Get full text

High-Resolution Genomic Profiling of Adult and Pediatric Core Binding Factor Acute Myeloid Leukemia Reveals New Recurrent Genomic Aberrations by Kühn, W.M. Michael, Radtke, Ina, Bullinger, Lars, Goorha, Salil, Cheng, Jinjun, Edelmann, Jennifer, Gohlke, Juliane, Su, Xiaoping, Paschka, Peter, Pounds, Stanley, Krauter, Jürgen, Ganser, Arnold, Quessar, Asmaa, Ribeiro, Raul, Gaidzik, Verena I., Shurtleff, Sheila, Krönke, Jan, Holzmann, Karlheinz, Ma, Jing, Schlenk, Richard F., Rubnitz, Jeffrey E., Döhner, Konstanze, Döhner, Hartmut, Downing, James R.

“…Abstract 849 Core-binding-factor (CBF) acute myeloid leukemia (AML) defined by the presence of t(8;21)(q22;q22) or inv(16)(p13.1q22)/t(16;16)(p13.1;q22) is…”
Get full text

Haploinsufficiency of Ebf1 Collaborates with BCR-ABL1 to Decrease the Latency of Acute Lymphoblastic Leukemia by Goorha, Salil, Lenny, Noel T., Miller, Christopher B, Perry, S. Scott, Su, Xiaoping, Williams, Richard T, Mullighan, Charles G, Downing, James R.

“…In previously published genome-wide copy number analysis of leukemic samples from 242 pediatric acute lymphoblastic leukemia (ALL) patients, we reported that…”
Get full text

High-Resolution Genome-Wide Profiling of DNA Copy Number Abnormalities and Gene Resequencing in Pediatric Acute Myeloid Leukemia (AML) by Radtke, Ina, Mullighan, Charles G., Ishii, Masami, Ma, Jing, Su, Xiaoping, Goorha, Salil, Ganti, Ramapriya, Cai, Zhongling, Phillips, Letha A., Pounds, Stanley B., Dalton, James, Raimondi, Susana C., Rubnitz, Jeffrey E., Ribeiro, Raul C., Shurtleff, Sheila A., Downing, James R.

“…To define the complement of genetic lesions in pediatric AML, we performed high resolution genome-wide analysis on bone marrow blasts from 111 cases using…”
Get full text

High Resolution Genomic Profiling Using Single Nucleotide Polymorphism Microarrays Identifies Multiple Novel Genomic Lesions in Pediatric Acute Lymphoblastic Leukemia by Mullighan, Charles G., Goorha, Salil, Radtke, Ina, Dalton, James, Ma, Jing, Pounds, Stanley B., Su, Xiaoping, Pui, Ching-Hon, Relling, Mary V., Evans, William E., Downing, James R.

“…To obtain a comprehensive registry of oncogenic lesions in pediatric acute lymphoblastic leukemia (ALL), we used Affymetrix single nucleotide polymorphism…”
Get full text

A set of commercially available fluorescent in-situ hybridization probes efficiently detects cytogenetic abnormalities in patients with chronic lymphocytic leukemia by Goorha, Salil, Glenn, Martha J., Drozd-Borysiuk, Elizabeth, Chen, Zhong

“…Purpose: To investigate a simplified panel of fluorescent in-situ hybridization (FISH) probes for evaluation of patients with chronic lymphocytic leukemia…”
Get full text

Genome-Wide Profiling of DNA Copy Number Abnormalities and Loss-Of-Heterozygosity in Pediatric Acute Myeloid Leukemia Using High-Resolution Single Nucleotide Polymorphism Microarrays by Radtke, Ina, Mullighan, Charles G., Goorha, Salil, Ma, Jing, Pounds, Stanley B., Su, Xiaoping, Kennedy, Alyssa L., Downing, Susanna M., Rubnitz, Jeffrey E., Ribeiro, Raul C., Shurtleff, Sheila A., Downing, James R.

“…To identify a comprehensive registry of oncogenic lesions in pediatric acute myeloblastic leukemia (AML), we used Affymetrix single nucleotide polymorphism…”
Get full text